Clinical trials: Cushing Syndrome

Cushing Syndrome, Cushing Disease

Open-label Treatment in Cushing's Syndrome

• Completed
• Age: 18 years and older
• Phase 3
• Results posted

This is a long-term, open-label extension study of levoketoconazole in participants with endogenous Cushing's Syndrome.

Trial name

OPTICS (NCT03621280)

Testing

Levoketoconazole

Where

30 sites in United States, Bulgaria and 9 more

Volunteers

51 people

Sponsor

Cortendo AB